Clinical trials: Thyroid Eye Disease

Graves´ Disease, Thyroid Associated Ophthalmopathy

Rituximab in the Treatment of Graves' Disease

• Completed
• Age: 18 years and older
• Phase 1/2
• Vaccines

Aim: In a phase II pilot study encompassing 20 patients with Graves' disease to evaluate the effect of rituximab: 1. Biochemically as assessed by markers of disease activity ( free T4, free T3, TSH, TSH-receptor antibodies…

Trial name

NCT00150111

Testing

Methimazole, Rituximab, Immunization with various vaccines

Where

2 sites in Denmark

Volunteers

20 people

Sponsor

Odense University Hospital